Close
Close
Treatment Database
arimoclomol
Trade Name not avaiable
Orphan Indication Inclusion body myositis
USA Market Approval
USA Designation Date 02-11-2017
Sponsor Orphazyme ApS
Ole Maaloes Vej 3, 2200 Copenhagen

More about Inclusion Body Myositis
Free Newsletter
Videos
by Scott Harwood
17 views
by Abidemi Uruejoma
17 views
by Scott Harwood
17 views